Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-09-10
Patil Neena M Files Jazz Pharmaceuticals plc (JAZZ) Form 4 - September 10, 2026
Patil Neena M sold 1.2K JAZZ shares worth $289.1K in this Form 4 filing, reported to the SEC on 2026-09-10.
- Insider
- Patil Neena M
- Issuer
- Jazz Pharmaceuticals plc JAZZ · NASDAQ
- Filed
- Period
- 2026-09-10
- Accession
- 0001783908-26-000022
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Patil Neena M | 2026-09-10 | Sell | 1.2K | $240.94 | $289.1K | Direct |
| Net change | −1.2K | −$289.1K | ||||
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc is a global biopharmaceutical company focused on developing and commercializing medicines for serious and often underserved conditions. Its portfolio includes treatments for sleep disorders, epilepsy, oncology, and other specialized therapeutic areas, with products such as Xywav, Epidiolex, Zepzelca, Rylaze, and Vyxeos supporting patients who may have limited treatment options. Jazz Pharmaceuticals plc works across the United States, Europe, and other international markets, serving healthcare providers, hospitals, and patients through prescription medicines and specialty care solutions. The company emphasizes rare disease and oncology medicines, making it an important participant in the global specialty pharmaceutical market. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals plc maintains a focused business model centered on identifying, developing, and commercializing targeted therapies for complex medical needs.
Track JAZZ insider activity
Get alerted when Jazz Pharmaceuticals plc executives buy or sell their shares.